---
schema_version: "secwatch.filing_event.v1"
accession: "0001438533-23-000012"
form_type: "8-K"
ticker: "TVTX"
cik: "0001438533"
company_name: "Travere Therapeutics, Inc."
filed_at: "2023-04-12T23:59:59+00:00"
generated_at: "2026-06-17T03:01:30.080085+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Travere Therapeutics dismisses BDO as auditor, appoints EY; discloses material weakness in internal controls

## Summary
- BDO dismissed as independent auditor effective April 6, 2023; EY appointed for fiscal year ending Dec 31, 2023.
- BDO's audit reports for FY2022 and FY2021 were unqualified with no adverse opinion or modifications.
- Disclosed material weakness in controls over pre-launch inventory contract affecting R&D expense timing; no restatement required.
- No disagreements with BDO on accounting principles or audit scope during 2022, 2021, or interim period through April 6, 2023.

## SEC filing metadata
- accession: 0001438533-23-000012
- form_type: 8-K
- ticker: TVTX
- cik: 0001438533
- company_name: Travere Therapeutics, Inc.
- filed_at: 2023-04-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438533/000143853323000012/0001438533-23-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438533/000143853323000012/tvtx-20230406.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438533-23-000012
- JSON: https://secwatch.observer/filing/0001438533-23-000012.json
- Plain text: https://secwatch.observer/filing/0001438533-23-000012.txt

## Key facts
- Auditor Changes
  Travere Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.
  - Action: engagement
  - Auditor: Ernst & Young LLP
  source text: the Audit Committee approved the appointment of EY as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438533/000143853323000012/0001438533-23-000012-index.htm
- Auditor Changes
  Travere Therapeutics, Inc. dismissed BDO USA, LLP as its auditor.
  - Action: dismissal
  - Auditor: BDO USA, LLP
  source text: On April 6, 2023, the Audit Committee dismissed BDO as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438533/000143853323000012/0001438533-23-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.